PureTech to Present at The SVB Leerink 10th Annual Global Healthcare Conference

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that Bharatt Chowrira, Ph.D., J.D., President and Chief of Business and Strategy, George Farmer, Ph.D., Chief Financial Officer, and Michael Chen, Ph.D., Head of Innovation, will participate in a fireside chat at the SVB Leerink 10^th Annual Global Healthcare Conference on Friday, February 26^th at 10:00 AM EST. A webcast of the presentation will be available at

Puretech Health

NASDAQ:PRTC

View PRTC Stock Overview →

PRTC Rankings

#3791 Ranked by Market Cap

N/A Ranked by Dividends

PRTC Latest News

May 13, 2026

PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference

Apr 29, 2026

PureTech Announces Annual Results for Year Ended December 31, 2025

Apr 29, 2026

PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange

Apr 27, 2026

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

Apr 22, 2026

PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

PRTC Latest SEC Filings

May 21, 2026

[424B3] PureTech Health plc Prospectus Filed Pursuant to Rule 424(b)(3)

May 6, 2026

[Form 4] PureTech Health plc Insider Trading Activity

May 11, 2026

[25] PureTech Health plc SEC Filing

May 11, 2026

[SCHEDULE 13G/A] PureTech Health plc Amended Passive Investment Disclosure

Apr 30, 2026

[Form 3] PureTech Health plc Initial Statement of Beneficial Ownership

PRTC Stock Data

Market Cap 424.03M

Float 24.34M

Industry Biotechnology

Sector Healthcare

Website Link

Country United States

City Boston